本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kazia Therapeutics Limited

10.36
-0.8000-7.17%
盤後10.560.2000+1.93%19:30 EDT
成交量:49.58萬
成交額:519.90萬
市值:1.45億
市盈率:-1.52
高:11.11
開:11.11
低:10.21
收:11.16
52周最高:17.40
52周最低:4.86
股本:1,400.69萬
流通股本:1,165.62萬
量比:1.96
換手率:4.25%
股息:- -
股息率:- -
每股收益(TTM):-6.8190
每股收益(LYR):-12.3849
淨資產收益率:-106.90%
總資產收益率:-25.70%
市淨率:4.38
市盈率(LYR):-0.84

資料載入中...

2024/06/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/06/01

SEC問詢函

Form CORRESP - Correspondence
2024/05/29

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/03

SEC問詢函

Form CORRESP - Correspondence
2024/01/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/07

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/09/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]